Clinical Trial Update: Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Phase 3 validation study for macimorelin as a diagnostic test for adult growth hormone deficiency has completed; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Macimorelin (macimorelin)

Snippet

Sponsor: AEterna Zentaris | Conditions: Growth Hormone Deficiency With Pituitary Anomalies | Phase 3 | Status: COMPLETED | Results posted: 2018-02-09